Moreover, comorbid conditions such as obesity, type 2 diabetes mellitus, and cardiovascular disease not only exacerbate MASLD progression but also involve HuR dysregulation in extrahepatic tissues, further contributing to liver dysfunction. The gene discussed is ELAVL1; the disease is obesity due to melanocortin 4 receptor deficiency.